Beckman Coulter

Brea, United States Founded: 1935 • Age: 91 yrs Acquired By Danaher
Clinical diagnostic products are manufactured for biomedical testing.

About Beckman Coulter

Beckman Coulter is a Healthcare company based in Brea (United States) founded in 1935 by Arnold O Beckman, and was acquired by Danaher in February 2011. Clinical diagnostic products are manufactured for biomedical testing. It operates on a Direct-to-Consumer (D2C) and Professional Services model. The company has 1,132 employees. Beckman Coulter has completed 8 acquisitions, including Advalytix AG, Cogenics and Cytobank. Its chief executive, as recorded, is J Robert Hurley. Its website beckmancoulter.com draws about 114 thousand monthly visits. Its Indian entity Beckman Coulter India Private Limited reported revenue of β‚Ή1,465 Cr. Beckman Coulter offers products and services including DxC 500 AU Chemistry Analyzer, DxI 9000 Immunoassay Analyzer, and DxA 5000 Total Lab Automation. Its focus areas include Medical Devices and Diagnostic Equipment. Its competitors include Cepheid, Bruker and Blackrock Neurotech; 2 of its 3 listed competitors have raised funding.

Company details

Beckman Coulter is involved in the development and provision of diagnostic solutions for clinical laboratories worldwide. The company focuses on areas such as chemistry, immunoassay, hematology, urinalysis, microbiology, and blood banking. Innovative products and automation systems are offered to enhance laboratory workflows and improve patient care outcomes. Solutions are provided for critical health issues including antimicrobial resistance, infectious diseases, cardiovascular disease, diabetes, and neurology. Through advanced diagnostics and digital tools, clinical decision-making is supported across various healthcare settings.

Key Metrics
  • Indian entity revenue
    ₹1,465 Cr

    FY 2025 · +11% YoY

  • Indian entity net profit
    ₹102 Cr

    FY 2025 · 7% margin

  • Indian entity EBITDA
    ₹284 Cr

    FY 2025 · 20% margin

  • Investors
    Danaher

    & 3 more

  • Employee Count
    1,132
  • Investments & Acquisitions
  • Acquired by
    Danaher

    (Feb 2011)

Products & Services of Beckman Coulter

Beckman Coulter offers a comprehensive portfolio of products and services, including DxC 500 AU Chemistry Analyzer, DxI 9000 Immunoassay Analyzer, and DxA 5000 Total Lab Automation.

DxC 500 AU Chemistry Analyzer
Chemistry Diagnostics

Used for analyzing chemical components in patient samples.

DxI 9000 Immunoassay Analyzer
Immunoassay Diagnostics

Employed for detecting specific proteins in blood samples.

DxA 5000 Total Lab Automation
Automation Systems

Designed to automate laboratory workflows for efficiency gains.

Apps and channels of Beckman Coulter

its YouTube channel Beckman Coulter Dx has 704 subscribers and 30 videos.

Beckman Coulter Dx
YouTube 704 subscribers 30 videos Science & Technology
Open channel

Videos from Beckman Coulter

The most watched videos on Beckman Coulter's YouTube channel, Beckman Coulter Dx (704 subscribers). Click a video to play it here.

Challenges in Today's Clinical Labs
389.4K views
Our Mission: Relentlessly Reimagine Healthcare, One Diagnosis at a Time
5.6K views
DxH 900 Hematology Analyzer
5.4K views
See the Science of Monocyte Distribution Width (MDW)
4.2K views

More on Beckman Coulter Dx.

Funding Insights of Beckman Coulter

  • Total Rounds 6
  • Investors Count 3

All 6 funding rounds of Beckman Coulter with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2020Grant––
Oct 2019$1.25MGrant––
Oct 2016$25,666Grant––
Jun 2015Grant––
Mar 2015$23,971Grant––
Jan 2014Grant––
Valuation history

4 investors in total: 4 institutional.

Investors in Beckman Coulter

Beckman Coulter has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Danaher, European Union and Public Health Emergency.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
phe.gov
Innovative health security solutions are funded by BARDA DRIVe.
drive.hhs.gov
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Dental equipment and medical instruments are manufactured for therapeutic areas.
1969danaher.com
Premium access

Investor details for Beckman Coulter

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Beckman Coulter India Private Limited (Beckman Coulter)

Beckman Coulter India Private Limited is the primary company behind Beckman Coulter. The board of Beckman Coulter India Private Limited currently have 4 directors; the longest-serving is Sameer Ashok Doshi, appointed in 2014. 18 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sameer Ashok Doshi
DIN 02701228
Director23 Jun 201412 yrs 4 moBeckman Coulter India Private Limited
Venkataraman Ravikumar
DIN 08287714
Director09 Nov 20206 yrsBeckman Coulter India Private Limited
Jamshyd Bomy Patravala
DIN 10789724
Director27 Sep 20242 yrs 1 moBeckman Coulter India Private Limited
Vinu Varghese
DIN 11230656
Director12 Aug 20251 yr 3 moBeckman Coulter India Private Limited

People of Beckman Coulter

674 people are tracked at Beckman Coulter (132 in leadership, 542 in team); the tracked headcount is 1,132.

NameRoleGroup
Arnold O Beckman
ex-FounderLeadership
J Robert Hurley
CEO & PresidentLeadership
Dave Berge
Sr. Director Of Hardware OperationsLeadership
Yael Sandowski
Director Of Product DevelopmentLeadership
James Garvin
Director of Open Innovation & Alliance Partnerships (Microbiology)Leadership
Robert Ostrom
Finance DirectorLeadership
Sharon Shinn
R&d DirectorLeadership
Michelle MacPherson
Senior Director Of Product Management, ImmunoassayLeadership
Morten Egeberg
Senior Director, Global Demand PlanningLeadership
Yip Ban Keat
Senior Director, APAC Supply ChainLeadership
Tim Harris
Vice President, Global Logistics And DistributionLeadership
Rachel Davison
Senior Director, Program ManagementLeadership
Alexandra Awad
Marketing Director, EemeaLeadership
Jeffrey Hill
Sr Director Of Service NACOLeadership
Murat M.
Regional Director Of OperationsLeadership
Zac Jun Zhu
Product Marketing DirectorLeadership
Maria Dimitrova-Martin
Senior Director Supply Chain, Global S&opLeadership
Sharon Dowd
Director, Global Product Marketing Chemistry & Immunoassay SolutionsLeadership
Cartha Donovan
Vice President Global Quality Management SystemsLeadership
Kathy Xu
Associate Director Of Clinical AffairsLeadership

654 more people are available in the full profile.

Premium access

Complete people profiles for Beckman Coulter

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Beckman Coulter

Figures of Beckman Coulter India Private Limited, the primary company behind Beckman Coulter, for FY 2025. Revenue was ₹1,465 Cr (+11% year on year). Net profit was ₹102 Cr (7% margin). EBITDA was ₹284 Cr (20% margin). Revenue has grown at a compounded annual rate of +11% over three years and +14% over five years.

  • ₹1,465 CrRevenue · FY 2025 · +11% YoY
  • ₹102 CrNet profit · 7% margin
  • ₹284 CrEBITDA · 20% margin
  • ₹42.96 CrPaid-up capital
  • 1,132Employees (provident fund records)
  • +11%Revenue CAGR, 3 years
  • +14%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Beckman Coulter India Private Limited are on its company page.

Premium access

Detailed financial statements for Beckman Coulter

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Beckman Coulter

Beckman Coulter has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Advalytix AG, Cogenics and Cytobank.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Predictive analytics for hospital administration and patient workflows are provided.
stocastic.comTowson, United States2016Oct 2022β€’β€’β€’β€’
Provider of products to measure antibody concentration and host cell stability
valitacell.comDublin, Ireland2014Sep 2022β€’β€’β€’β€’
Cloud-based platform for single-cell data storage and analysis is provided.
cytobank.orgSanta Clara, United States2009Jun 2019β€’β€’β€’β€’
Acoustic liquid handling is developed for life science research.
labcyte.comSunnyvale, United States2000Jan 2019β€’β€’β€’β€’
Flow cytometer research applications are developed for nanoscale object detection.
xitogen.comSuzhou, China2013Apr 2014β€’β€’β€’β€’
Provides single cell molecular analysis, and the miniaturization of biological tests for R&D
advalytix.comMunich, Germany2000Jun 2009β€’β€’β€’β€’
Gene synthesis, sequencing, and molecular biology services are provided.
cogenics.com0Apr 2009$17M
Chemiluminescent reagents are manufactured for biotechnology applications.
lumigen.comSouthfield, United States1987Oct 2006$185M
Premium access

Complete acquisition details for Beckman Coulter

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Beckman Coulter

12 dated milestones of Beckman Coulter across 87 years, from founding to its latest funding, stage changes and deals.

  1. Founded Beckman Coulter is founded.
  2. Acquisition Acquires Lumigen.
  3. Acquisition Acquires Cogenics.
  4. Acquisition Acquires Advalytix AG.
  5. Exit Acquired by Danaher.
  6. Funding First funding round.
  7. Acquisition Acquires Xitogen Technologies.
  8. Acquisition Acquires LabCyte.
  9. Acquisition Acquires Cytobank.
  10. Funding Latest funding round, Grant,.
  11. Acquisition Acquires Valitacell.
  12. Acquisition Acquires StoCastic.

Competitors of Beckman Coulter

Beckman Coulter has 3 listed competitors in our database, 2 of them funded. They include Cepheid, Bruker and Blackrock Neurotech.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cepheid.com1996Sunnyvale, United States$19.1M1,299
Developer of molecular diagnostic testing solutions
bruker.com1960United States9,707
Diversified research instrument systems are manufactured and supplied.
blackrockneurotech.com2008Salt Lake, United States$22.37M127
Medical devices for neurological therapies are developed.
Premium access

Detailed competitors of Beckman Coulter

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Beckman Coulter

The website of Beckman Coulter (beckmancoulter.com) receives about 113.9K visits a month.

  • Monthly visits
    113.9K

    ▲ 21.3% vs previous month

Similar websites

Websites whose visitors overlap most with Beckman Coulter. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
core-genomics.blogspot.com
core-genomics.blogspot.com
100%
–
bio-rad.com
100%
665.2K#79,666View details
rpicorp.com
rpicorp.com
96%
#1,292,794–
miltenyibiotec.com
93%
192.6K#205,424View details
denovosoftware.com
90%
28.1K#1,461,335View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Beckman Coulter

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Beckman Coulter (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Beckman Coulter

Premium access

Complete news archive for Beckman Coulter

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Beckman Coulter

Beckman Coulter was founded in 1935 and raised its 1st funding round 79 years after it was founded.

Beckman Coulter is headquartered in Brea, United States. It is registered at Brea, California, United States.

J Robert Hurley is the CEO of Beckman Coulter, as recorded in our data.

Beckman Coulter has 1,132 employees.

The primary company behind Beckman Coulter, Beckman Coulter India Private Limited, reported revenue of β‚Ή1,465 Cr for FY 2025, up 11% year on year.

Beckman Coulter is involved in the development and provision of diagnostic solutions for clinical laboratories worldwide. The company focuses on areas such as chemistry, immunoassay, hematology, urinalysis, microbiology, and blood banking. Innovative products and automation systems are offered to enhance laboratory workflows and improve patient care outcomes. Solutions are provided for critical health issues including antimicrobial resistance, infectious diseases, cardiovascular disease, diabetes, and neurology. Through advanced diagnostics and digital tools, clinical decision-making is supported across various healthcare settings.

Beckman Coulter's top competitors include Cepheid, Blackrock Neurotech and Bruker.

Beckman Coulter offers DxC 500 AU Chemistry Analyzer, DxI 9000 Immunoassay Analyzer, and DxA 5000 Total Lab Automation.

Beckman Coulter has made 8 acquisitions, including Advalytix AG, Cogenics, and Cytobank.

Beckman Coulter has 4 investors. Key investors include Danaher, European Union, Public Health Emergency, and BARDA DRIVe.

Beckman Coulter operates through Beckman Coulter India Private Limited.

Yes. Beckman Coulter was acquired by Danaher in February 2011.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available